Exclusive: GPs alter prescribing habits to beat antibiotic resistance

GPs have reduced prescribing of most antibacterial drugs that experts say should be restricted and protected to limit rising antibiotic resistance, analysis of data over the past decade reveals.

Prescription: GPs have reduced use of most protected antibiotics (Photo: JH Lancy)
Prescription: GPs have reduced use of most protected antibiotics (Photo: JH Lancy)

UK GPs have cut down on prescribing drugs the World Health Organisation (WHO) has prioritised for protection, NHS Digital data on antibacterial drugs dispensed in the community suggests.

The WHO launched its updated Essential Medicines List last week, which included a new method of categorising antibacterials used to treat common infections into three groups – access, watch and reserve.

It recommended that only drugs in the ‘access’ group should be readily used as first- or second-line options for common infections, while drugs in the ‘watch’ group have higher resistance potential and should be used more sparingly.

Those in the ‘reserve’ group should treated as last-resort options to be used when other alternatives have failed, it recommended.

Antibiotic prescribing

Analysis by GPonline of official prescribing data over the last decade shows that GPs have already made a significant effort to cut down on drugs prioritised for protection in the WHO’s ‘watch’ list, which includes quinolones, 3rd-generation cephalosporins and macrolides.

GPs have slashed use of norfloxacin by 99.9% over the last decade, cutting use from over 61,000 prescriptions in 2006 to just 47 in 2016. Use of cefpodoxime and nalidixic acid were also cut by 99.8% and 99.7%, respectively.

Use of erythromycin more than halved to 896,000 prescriptions in 2016, while levofloxacin halved to 19,600 and ofloxacin halved to 27,800.

The only drug that has risen in use over the last decade that is featured exclusively on the WHO’s 'watch' list is ertapenem sodium, which rose from 37 prescriptions to 1,110.

Prescriptions of drugs on the ‘access’ list has significantly decreased for some drugs, while others have been prescribed in much larger volumes over the last 10 years.

Ampicillin prescriptions dropped 91% to 2,120 prescriptions, cefalexin by two thirds to 855,000 and amoxicillin use fell by a more conservative 8% to 11.6m.

Antibiotic resistance

But use of doxycycline monohydrate tripled to 2.7m prescriptions, nitrofurantoin increased almost six-fold to 2.6m and clarithromycin use tripled to 2.4m.

Use of drugs on the 'reserve' list – aztreonam, daptomycin, linezolid and tigecycline – has increased over the last 10 years, but all were used in very low numbers.

The results suggest that overall the number of antibacterial drugs prescribed rose 4% from 2006 to 2016 – but use has dropped off 11% compared to 2012, the year with the highest proportion of overall drugs prescribed.

GPC clinical and prescribing subcommittee chair Dr Andrew Green said: ‘The WHO classification is useful, the problem of antibiotic resistance really is one of the main challenges of this century.

‘It is pleasing that GP prescribing of the "watch" drugs has decreased so markedly, this is due not only to the efforts of GPs but also the academics, microbiologists and public health doctors who have worked hard to keep this subject at the forefront of our minds.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NICE recommends digital CBT for children with mild depression

NICE recommends digital CBT for children with mild depression

Children and young people with mild depression should have access to digital cognitive...

GPs taking early retirement triple in a decade as tax limits hit workforce

GPs taking early retirement triple in a decade as tax limits hit workforce

Numbers of GPs taking early retirement have tripled over the past decade as tighter...

BMA safety warning as pharmacists gain power to switch prescriptions

BMA safety warning as pharmacists gain power to switch prescriptions

Pharmacists are set to be granted emergency powers to alter patients' prescriptions...

GP funding could rise £60m through deals on QOF, networks and digital health

GP funding could rise £60m through deals on QOF, networks and digital health

GP leaders hope to trigger a 1% boost to practice funding from April - on top of...

GP trainees unfairly denied £20,000 golden hello payments, says BMA

GP trainees unfairly denied £20,000 golden hello payments, says BMA

Some GP trainees expecting £20,000 golden hellos for working in under-doctored areas...

The survival of GP partnerships depends on a credible workforce plan

The survival of GP partnerships depends on a credible workforce plan

The GP partnership review and the NHS long-term plan set out welcome proposals to...